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In obese children with obstructive sleep apnoea insulin resistance is common while lipids do not
show a clear pattern http://ow.ly/XNR9s
In adults, obstructive sleep apnoea (OSA) is often associated with metabolic alterations. Although obesity
is a major culprit [1], large epidemiological studies have reported a metabolic risk associated with OSA
that is independent of obesity. In particular, meta-analyses have shown that effective treatment of OSA by
continuous positive airway pressure (CPAP) improves glycaemic control in both diabetic [2] and
nondiabetic patients [3].
Intermittent hypoxia is an important mechanism by which OSA affects metabolism, as supported by
experimental observations showing that intermittent hypoxia negatively interferes with both glucose and
lipid metabolism [4, 5]. Altered sleep structure, as often found in OSA, may also play an important role.
In adult humans, experimental sleep fragmentation [6] and deprivation of slow wave sleep (SWS) [7]
decreased insulin sensitivity. In healthy adolescents, two studies found that insulin sensitivity was
negatively correlated to stage 1 non-rapid eye movement (non-REM) sleep, and positively to SWS duration
[8, 9]. Furthermore, in another population of healthy adolescents, partial sleep deprivation, with preserved
SWS and a reduced amount of REM sleep, was followed by an increase in insulin resistance [10]. A
correlation between short sleep duration and insulin resistance has also been found with actigraphic
studies both in adolescents [11, 12] and in younger children [13].
Paediatric OSA shows major differences compared with the adult disease [14]. First, the number of
respiratory events and the degree of nocturnal hypoxaemia are usually lower in children than in adults.
Second, sleep duration is physiologically longer in children than in adults and respiratory events, although
possibly causing some sleep fragmentation, are associated with a sleep structure that appears to be better
preserved than in adults. Third, duration of disease and exposure to additional risk factors for several
complications is limited in children, as opposed to the decades of exposure to sleep disordered breathing
(SDB) and risk factors typical of adult patients. Therefore, differences between adults and children with
OSA could explain a different impact on metabolism. The picture is even more complex if we consider
that paediatric disease has two main phenotypes: one typical of lean children with adenotonsillar
hypertrophy, which usually occurs at a younger age and has a similar prevalence in both sexes; and one
typical of obese children that is more similar to adult OSA and usually appears in adolescence, more often
in males [15]. Onset of puberty is an additional factor known to affect metabolism in children, increasing
insulin resistance at least in males [16]. The impact of all these variables, and the small sample size of
several paediatric studies, probably contribute to the difficulties in clear interpretation of the apparently
conflicting data available in the current literature.
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The paper by KOREN et al. [17] in this issue of the European Respiratory Journal reports a large amount of
metabolic data in over 400 children with SDB aged 5–12 years. The data indicate that both obesity and
sleep fragmentation in OSA are significantly associated with altered metabolic variables, including insulin
resistance and lipid profile, whereas the frequency of nocturnal respiratory events or severity of nocturnal
hypoxaemia exerts a minor effect, if any. The results of this study reinforce the conclusions of studies that
demonstrated a prominent role of obesity [17–21] and sleep structure [22, 23] as determinants of
alterations in insulin resistance/sensitivity in children with OSA, but are at odds with other studies
indicating an independent influence of OSA [24–31].
Important heterogeneity in the design of investigations, and even more heterogeneity in the populations under
study, could partly account for the large disagreements in the literature. Even studies with similar populations
did not always report similar conclusions, but some trends may be identified (table 1). Most studies including
only obese children found a significant effect of OSA on glucose metabolism [24, 26–28, 31–32], in agreement
with experimental data showing an adverse interaction of obesity and intermittent hypoxia with metabolism
[33]. Studies including only non-obese subjects did not show any significant association [19, 34, 35], but only
examined preadolescent subjects. No similar studies are available in adolescents, possibly because of the low
TABLE 1 Summary of studies on glucose and lipid metabolism in paediatric obstructive sleep apnoea (OSA) according to age
and body weight
Insulin resistance/sensitivity Lipid measurements
Worse in OSA Not worse in OSA At least one worse in OSA Not worse in OSA
Early childhood
Normal body weight KADITIS et al. [19]
STEFANINI et al. [34]
SURI et al. [35]
Decreased HDL and
increased VLDL in OSA [34]
Unchanged triglycerides, and
increased total cholesterol,
HDL and LDL in OSA [35]
Triglycerides,
total cholesterol
and HDL [19]
Overweight/obese CAMINITI et al. [31]
BHUSHAN et al. [26]
Wide range of body weights APOSTOLIDOU et al. [36]
KELLY et al. [37]
KOREN et al. [17]
Adolescence
Normal body weight
Overweight/obese KELLY et al. [37]
HANNON et al. [28]
WATSON et al. [30]
BHUSHAN et al. [27]
Increased triglycerides, and
unchanged total cholesterol,
HDL and LDL in OSA [20]
Increased triglycerides, and
unchanged total cholesterol,
HDL and LDL in OSA [27]
Triglycerides,
total cholesterol,
HDL and LDL [28]
Wide range of body weights REDLINE et al. [29] DEBOER et al. [38]
KELLY et al. [37]
Unchanged triglycerides, total
cholesterol and HDL, and
increased LDL in OSA [29]
Paediatric age (3–18 years)
Normal body weight Unchanged triglycerides, total
cholesterol and LDL, and
decreased HDL in OSA [40]
Overweight/obese DE LA EVA et al. [24]
LI et al. [32]
CANAPARI et al. [20]
FLINT et al. [39]
Increased triglycerides, and
unchanged total cholesterol,
HDL and LDL in OSA [20]
Increased triglycerides, and
unchanged total cholesterol
and HDL in OSA [39]
Wide range of body weights VERHULST et al. [25] TAUMAN et al. [18]
SHAMSUZZAMAN et al. [21]
Increased triglycerides and
total cholesterol, and
decreased HDL in OSA [25]
HDL: high-density lipoprotein cholesterol; VLDL: very low-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol.
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prevalence of OSA in lean adolescents. Studies including both obese and non-obese children with a wide age
range do not convey a uniform picture [18, 21, 25, 29, 36–38]. Pubertal state, in addition to age, could exert
some influence [37], although a study accounting for the Tanner stage did not support this hypothesis [39].
In addition to data on glucose metabolism, the paper by KOREN et al. [17] provides a wealth of information
on lipids. Table 1 summarises the result of the available studies that reported data on lipid profiles in OSA
children. Unfortunately, the picture is far from being clear. Some studies did not find any relationship
between OSA and lipids [19, 28], while the results of other studies were discordant about which aspects of
lipid metabolism may be affected by OSA, irrespective of age and obesity state of the children [20, 25, 27,
29, 34, 35, 39, 40].
Among the longitudinal studies, which are available only in young children undergoing
adenotonsillectomy or followed without interventions, one showed an improvement in glucose and lipid
metabolism at least in obese subjects after adenotonsillectomy [41], one observed an improvement in total
cholesterol only [42], and one found unchanged glucose or lipid metabolism [43]. The variable degree of
resolution of respiratory events during sleep and weight gain commonly occurring in lean children after
adenotonsillectomy complicate this approach [14].
The study by KOREN et al. [17] represents the largest published on metabolic effects of OSA in children, to
date, and has to be regarded as one of the most important in this field. The focus on only one age group,
i.e. young children, is another merit of this paper. To date, altogether the literature seems to suggest that
in children age, obesity and, perhaps, pubertal state modulate the relationship between OSA and glucose
metabolism, but the real effect of each of these factors needs to be better clarified with large studies that
are homogeneous for sample characteristics. OSA severity has mostly been analysed in terms of apnoea–
hypopnoea index, and more rarely in terms of nocturnal hypoxaemia, although intermittent hypoxia could
be an important mediator of metabolic effects [4, 5]. Besides, the potential importance of the distribution
of respiratory disorders in non-REM versus REM sleep [44] has not been addressed in children. Finally,
the independent role of sleep fragmentation in the context of respiratory events during sleep should be
better clarified. As regards lipid metabolism, the picture is poorly defined in both children and adults.
However, some factors that could importantly influence serum lipids, like diet or physical activity, have
rarely been considered and should be assessed in future studies. In conclusion, studies on the metabolic
effects of OSA in children are becoming numerous [14], but the many factors at play mean the puzzle is
still far from a definitive solution.
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